Semnur Pharmaceuticals, Inc. (SMNR)
14.00
+5.00
(+55.56%)
USD |
OTCM |
Dec 15, 16:00
Semnur Pharmaceuticals EPS Diluted (Quarterly): -0.7566 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Scilex Holding Co. | -22.17 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -152.59M |
| Total Expenses (Quarterly) | 152.59M |
| Enterprise Value | 46.36M |
| Earnings Yield | -8.65% |
| Normalized Earnings Yield | -8.648 |